메뉴 건너뛰기




Volumn 63, Issue 5, 2003, Pages 1159-1168

Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase IIα

Author keywords

[No Author keywords available]

Indexed keywords

1,2 BIS(3,5 DIOXOPIPERAZIN 1 YL)ETHANE; DNA TOPOISOMERASE (ATP HYDROLYSING); MITINDOMIDE; PIPERAZINE DERIVATIVE; PIPERAZINEDIONE;

EID: 0038068957     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.5.1159     Document Type: Article
Times cited : (6)

References (31)
  • 1
    • 0032189962 scopus 로고    scopus 로고
    • Catalytic inhibitors of DNA topoisomerase II
    • Andoh T and Ishida R (1998) Catalytic inhibitors of DNA topoisomerase II. Biochim Biophys Acta 1400:155-171.
    • (1998) Biochim Biophys Acta , vol.1400 , pp. 155-171
    • Andoh, T.1    Ishida, R.2
  • 2
    • 0032584727 scopus 로고    scopus 로고
    • Analysis of a core domain in Drosophila DNA topoisomerase II. Targeting of an antitumor agent ICRF-159
    • Chang S, Hu T, and Hsieh TS (1998) Analysis of a core domain in Drosophila DNA topoisomerase II. Targeting of an antitumor agent ICRF-159. J Biol Chem 273:19822-19828.
    • (1998) J Biol Chem , vol.273 , pp. 19822-19828
    • Chang, S.1    Hu, T.2    Hsieh, T.S.3
  • 3
    • 0028174984 scopus 로고
    • DNA topoisomerases: Essential enzymes and lethal targets
    • Chen AY and Liu LF (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218.
    • (1994) Annu Rev Pharmacol Toxicol , vol.34 , pp. 191-218
    • Chen, A.Y.1    Liu, L.F.2
  • 4
    • 0030733491 scopus 로고    scopus 로고
    • Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site
    • Hasinoff BB, Creighton AM, Kozlowska H, Thampatty P, Allan WP, and Yalowich JC (1997) Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site. Mol Pharmacol 52:839-845.
    • (1997) Mol Pharmacol , vol.52 , pp. 839-845
    • Hasinoff, B.B.1    Creighton, A.M.2    Kozlowska, H.3    Thampatty, P.4    Allan, W.P.5    Yalowich, J.C.6
  • 5
    • 0029891617 scopus 로고    scopus 로고
    • ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors
    • Holm B, Jensen PB, and Sehested M (1996) ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors. Cancer Chemother Pharmacol 38:203-209.
    • (1996) Cancer Chemother Pharmacol , vol.38 , pp. 203-209
    • Holm, B.1    Jensen, P.B.2    Sehested, M.3
  • 6
    • 0031802032 scopus 로고    scopus 로고
    • Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide
    • Holm B, Sehested M, and Jensen PB (1998) Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide. Clin Cancer Res 4:1367-1373.
    • (1998) Clin Cancer Res , vol.4 , pp. 1367-1373
    • Holm, B.1    Sehested, M.2    Jensen, P.B.3
  • 7
    • 0030058786 scopus 로고    scopus 로고
    • Functional expression of human topoisomerase II alpha in yeast: Mutations at amino acids 450 or 803 of topoisomerase II alpha result in enzymes that can confer resistance to anti-topoisomerase II agents
    • Hsiung Y, Jannatipour M, Rose A, McMahon J, Duncan D, and Nitiss JL (1996) Functional expression of human topoisomerase II alpha in yeast: mutations at amino acids 450 or 803 of topoisomerase II alpha result in enzymes that can confer resistance to anti-topoisomerase II agents. Cancer Res 56:91-99.
    • (1996) Cancer Res , vol.56 , pp. 91-99
    • Hsiung, Y.1    Jannatipour, M.2    Rose, A.3    McMahon, J.4    Duncan, D.5    Nitiss, J.L.6
  • 8
    • 0037155222 scopus 로고    scopus 로고
    • ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization
    • Hu T, Sage H, and Hsieh TS (2002) ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization. J Biol Chem 277:5944-5951.
    • (2002) J Biol Chem , vol.277 , pp. 5944-5951
    • Hu, T.1    Sage, H.2    Hsieh, T.S.3
  • 12
    • 0034284722 scopus 로고    scopus 로고
    • N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance
    • Jensen LH, Wessel I, Moller M, Nitiss JL, Sehested M, and Jensen PB (2000b) N-Terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance. FEBS Lett 480:201-207.
    • (2000) FEBS Lett , vol.480 , pp. 201-207
    • Jensen, L.H.1    Wessel, I.2    Moller, M.3    Nitiss, J.L.4    Sehested, M.5    Jensen, P.B.6
  • 13
    • 0000191348 scopus 로고    scopus 로고
    • DNA topoisomerase II rescue by catalytic inhibitors: A new strategy to improve the antitumor selectivity of etoposide
    • Jensen PB and Sehested M (1997) DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide. Biochem Pharmacol 54:755-759.
    • (1997) Biochem Pharmacol , vol.54 , pp. 755-759
    • Jensen, P.B.1    Sehested, M.2
  • 14
    • 0033817796 scopus 로고    scopus 로고
    • Treatment of anthracycline extravasation with dexrazoxane
    • Langer SW, Sehested M, and Jensen PB (2000) Treatment of anthracycline extravasation with dexrazoxane. Clin Cancer Res 6:3680-3686.
    • (2000) Clin Cancer Res , vol.6 , pp. 3680-3686
    • Langer, S.W.1    Sehested, M.2    Jensen, P.B.3
  • 15
    • 0024316466 scopus 로고
    • DNA topoisomerase poisons as antitumor drugs
    • Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-375.
    • (1989) Annu Rev Biochem , vol.58 , pp. 351-375
    • Liu, L.F.1
  • 16
    • 0034723405 scopus 로고    scopus 로고
    • Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193
    • Morris SK, Baird CL, and Lindsley JE (2000) Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193. J Biol Chem 275:2613-2618.
    • (2000) J Biol Chem , vol.275 , pp. 2613-2618
    • Morris, S.K.1    Baird, C.L.2    Lindsley, J.E.3
  • 17
    • 0028697603 scopus 로고
    • Roles of DNA topoisomerases in chromosomal replication and segregation
    • Nitiss JL (1994) Roles of DNA topoisomerases in chromosomal replication and segregation. Adv Pharmacol 29A:103-134.
    • (1994) Adv Pharmacol , vol.29 A , pp. 103-134
    • Nitiss, J.L.1
  • 18
    • 0033618406 scopus 로고    scopus 로고
    • 2-terminal fragments of yeast DNA topoisomerase II
    • 2-terminal fragments of yeast DNA topoisomerase II. J Biol Chem 274:21688-21694.
    • (1999) J Biol Chem , vol.274 , pp. 21688-21694
    • Olland, S.1    Wang, J.C.2
  • 19
    • 0033851025 scopus 로고    scopus 로고
    • Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIa
    • Patel S, Jazrawi E, Creighton AM, Austin CA, and Fisher LM (2000) Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIa. Mol Pharmacol 58:560-568.
    • (2000) Mol Pharmacol , vol.58 , pp. 560-568
    • Patel, S.1    Jazrawi, E.2    Creighton, A.M.3    Austin, C.A.4    Fisher, L.M.5
  • 21
    • 0028345406 scopus 로고
    • Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp
    • Roca J, Ishida R, Berger JM, Andoh T, and Wang JC (1994) Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci USA 91:1781-1785.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 1781-1785
    • Roca, J.1    Ishida, R.2    Berger, J.M.3    Andoh, T.4    Wang, J.C.5
  • 22
    • 0026448670 scopus 로고
    • The capture ofa DNA double helix by an ATP-dependent protein clamp: A key step in DNA transport by type II DNA topoisomerases
    • Roca J and Wang JC (1992) The capture ofa DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases. Cell 71:833-840.
    • (1992) Cell , vol.71 , pp. 833-840
    • Roca, J.1    Wang, J.C.2
  • 23
    • 0028334718 scopus 로고
    • DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanism
    • Roca J and Wang JC (1994) DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism. Cell 77:609-616.
    • (1994) Cell , vol.77 , pp. 609-616
    • Roca, J.1    Wang, J.C.2
  • 24
    • 0022524870 scopus 로고
    • A quantitative decatenation assay for type II topoisomerases
    • Sahai BM and Kaplan JG (1986) A quantitative decatenation assay for type II topoisomerases. Anal Biochem 156:364-379.
    • (1986) Anal Biochem , vol.156 , pp. 364-379
    • Sahai, B.M.1    Kaplan, J.G.2
  • 25
    • 0032054222 scopus 로고    scopus 로고
    • Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: A Tyr49Phe mutation confers highlevel resistance to bisdioxopiperazines
    • Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, and Jensen PB (1998) Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers highlevel resistance to bisdioxopiperazines. Cancer Res 58:1460-1468.
    • (1998) Cancer Res , vol.58 , pp. 1460-1468
    • Sehested, M.1    Wessel, I.2    Jensen, L.H.3    Holm, B.4    Oliveri, R.S.5    Kenwrick, S.6    Creighton, A.M.7    Nitiss, J.L.8    Jensen, P.B.9
  • 26
    • 0031684652 scopus 로고    scopus 로고
    • Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: A potent tool for identification and characterization of topoisomerase II-targeting antitumour agents
    • van Hille B and Hill BT (1998) Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agents. Cancer Chemother Pharmacol 42:345-356.
    • (1998) Cancer Chemother Pharmacol , vol.42 , pp. 345-356
    • Van Hille, B.1    Hill, B.T.2
  • 27
    • 0030014783 scopus 로고    scopus 로고
    • DNA topoisomerases
    • Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65:635-692.
    • (1996) Annu Rev Biochem , vol.65 , pp. 635-692
    • Wang, J.C.1
  • 28
    • 0027275284 scopus 로고
    • Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: Expression of a functional recombinant human DNA topoisomerase II alpha in yeast
    • Wasserman RA, Austin CA, Fisher LM, and Wang JC (1993) Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast. Cancer Res 53:3591-3596.
    • (1993) Cancer Res , vol.53 , pp. 3591-3596
    • Wasserman, R.A.1    Austin, C.A.2    Fisher, L.M.3    Wang, J.C.4
  • 29
    • 0033565646 scopus 로고    scopus 로고
    • Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the walker A consensus ATP binding domain of the alpha isoform
    • Wessel I, Jensen LH, Jensen PB, Falck J, Rose A, Roerth M, Nitiss JL, and Sehested M (1999) Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the walker A consensus ATP binding domain of the alpha isoform. Cancer Res 59:3442-3450.
    • (1999) Cancer Res , vol.59 , pp. 3442-3450
    • Wessel, I.1    Jensen, L.H.2    Jensen, P.B.3    Falck, J.4    Rose, A.5    Roerth, M.6    Nitiss, J.L.7    Sehested, M.8
  • 30
    • 0037024363 scopus 로고    scopus 로고
    • Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the walker A ATP binding site of topoisomerase IIalpha
    • Wessel I, Jensen LH, Renodon-Cornière A, Sorensen TK, Nitiss JL, Jensen PB, and Sehested M (2002) Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the walker A ATP binding site of topoisomerase IIalpha. FEBS Lett 520:161-166.
    • (2002) FEBS Lett , vol.520 , pp. 161-166
    • Wessel, I.1    Jensen, L.H.2    Renodon-Cornière, A.3    Sorensen, T.K.4    Nitiss, J.L.5    Jensen, P.B.6    Sehested, M.7
  • 31
    • 0024519424 scopus 로고
    • Inducible overexpression, purification and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae
    • Worland ST and Wang JC (1989) Inducible overexpression, purification and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J Biol Chem 264:4412-4416.
    • (1989) J Biol Chem , vol.264 , pp. 4412-4416
    • Worland, S.T.1    Wang, J.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.